Thermo Fisher Scientific manufactures and sells instruments, reagents, consumables and software used for research, diagnostics and biopharmaceutical production. The company serves scientific laboratories, hospitals, pharmaceutical companies and biotechnology firms with tools for analysis, genetic research, cell biology and clinical testing. Its comprehensive product range supports end-to-end workflows from discovery through manufacturing and healthcare delivery.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 10,364 | — | 1,507 | -22.7% |
| Q2 2025 | 10,854 | — | 1,617 | -21.1% |
| Q3 2025 | 11,122 | — | 1,616 | -19.9% |
| Q4 2025 | 12,215 | — | 1,964 | -15.8% |
| Q1 2026 | 11,005 | 6.2% | 1,651 | 9.6% |
| Q2 2026 | 11,994 | 10.5% | 1,736 | 7.4% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Wells Fargo & Company (WFC), Mitsubishi UFJ Financial Group, Inc. (MUFG), GE Vernova Inc. (GEV), Toyota Motor Corporation (TM), Arista Networks, Inc. (ANET), International Business Machines Corporation (IBM)